Citations

Clear

3485 citation(s) found for "Sy, Sarah".

Nomenclature for human and animal fungal pathogens and diseases: a proposal for standardized terminology
Walsh, Thomas J. , Ahmed, Sarah , Alastruey‐Izquierdo, Ana , Arendrup, Maiken Cavling , Borman, Andrew M. , Colgrove, Robert C. , Cornely, Oliver A. , Filkins, Laura , Groll, Andreas H. , Haase, Gerhard , Hubka, Vít , Kwon-Chung, June , Song, Yinggai , Vilela, Rachel, Vitale, Roxana G. , Wengenack, Nancy L. , de Hoog, Sybren , Walsh, Thomas J , Alastruey-Izquierdo, A , Arendrup, Maiken Cavling , Borman, Andrew , Filkins, Laura , Gené, Josepa , Groll, Andreas H , Hoenigl, Martin , Kidd, Sarah E , Kus, Julianne V , Kwon-Chung, Kyung J , Lockhart, Shawn R. , Meis, Jacques F , Mendoza, Leonel , Nguyen, M Hong , Vitale, Roxana G , Wengenack, Nancy L , White, Lewis , Zhang, Sean X , Cornely, Oliver A , Ahmed, Sarah A , Chen, Wen , Chowdhary, Anuradha , Denning, David W. , Dufresne, Philippe J. , Gangneux, Jean‐Pierre , Guillot, Jacques , Halliday, Catriona , Hawksworth, David L. , Hay, Roderick J. , Hoenigl, Martin , Jagielski, Tomasz , Kandemir, Hazal , Kidd, Sarah , Kus, Julianne V. , Kwon‐Chung, June , Meyer, Wieland , Song, Yinggai , Sorrell, Tania Christine , Stielow, J. Benjamin , Ostrosky‐Zeichner, Luis , Zhang, Sean X.

Mayo Clinic

Journal of Clinical Microbiology | November 11, 2024 | Volume: 62 | Issue: 12 | Pages: No page available

10.1128/jcm.00937-24 | PMID 39526838 Get It

ABSTRACT Medically important pathogenic fungi invade vertebrate tissue and are considered primary when part of their nature life cycle is associated with an animal host and are usually able to infect immunocompetent hosts. Opportunistic fungal pathogens complete their life cycle in environmental habitats or occur as commensals within or on the vertebrate body, but under certain conditions can thrive upon infecting humans. The extent of host damage in opportunistic infections largely depends on the portal and modality of entry as well as on the host’s immune and metabolic status. Diseases caused by primary pathogens and common opportunists, causing the top approximately 80% of fungal diseases [D. W. Denning, Lancet Infect Dis, 24:e428–e438, 2024, https://doi.org/10.1016/S1473-3099(23)00692-8 ], tend to follow a predictive pattern, while those by occasional opportunists are more variable. For this reason, it is recommended that diseases caused by primary pathogens and the common opportunists are named after the etiologic agent, for example, histoplasmosis and aspergillosis, while this should not be done for occasional opportunists that should be named as [causative fungus] [clinical syndrome], for example, Alternaria alternata cutaneous infection. The addition of a descriptor that identifies the location or clinical type of infection is required, as the general name alone may cover widely different clinical syndromes, for example, “rhinocerebral mucormycosis.” A list of major recommended human and animal disease entities (nomenclature) is provided in alignment with their causative agents. Fungal disease names may encompass several genera of etiologic agents, consequently being less susceptible to taxonomic changes of the causative species, for example, mucormycosis covers numerous mucormycetous molds.
Decision fatigue in hospital settings: A scoping review
Perry, Kelsey , Jones, Sarah , Stumpff, Julia , Kruer, Rachel , Czosnowski, Lauren M., Kashiwagi, Deanne T. , Kara, Areeba , Kara, Areeba Y

Mayo Clinic

Journal of Hospital Medicine | November 11, 2024 | Volume: 20 | Issue: 4 | Pages: 385-395

10.1002/jhm.13550 | PMID 39526649 Get It

Abstract Background “Decision Fatigue” (DF) describes the impaired ability to make decisions because of repeated acts of decision‐making. Objectives We conducted a scoping review to describe DF in inpatient settings. Methods To be included, studies should have explored a clinical decision, included a mechanism to account for the order of decision making, and be published in English in or after the year 2000. Six databases were searched. Retrieved citations were screened and retained studies were reviewed against the inclusion criteria. References of included studies were manually searched, and forward citation searches were conducted to capture relevant sources. Results The search retrieved 12,781 citations, of which 41 were retained following screening. Following review, 16 studies met the inclusion criteria. Half were conference abstracts and none examined hospitalists. Emergency medicine and intensive care settings were the most frequently studied clinical environments ( n = 13, 81%). All studies were observational. The most frequently examined decisions were about resource utilization ( n = 8, 50%), however only half of these examined downstream clinical outcomes. Decision quality against prespecified standards was examined in four (25%) studies. Work environment and patient attributes were often described but not consistently accounted for in analyses. Clinician attributes were described in four (25%) investigations. Findings were inconsistent: both supporting and refuting DF's role in the outcome studied. Conclusions The role of clinician, patient, and work environment attributes in mediating DF is understudied. Similarly, the context surrounding the decision under study require further explication and when assessing resource use and decision quality, adjudication should be made against prespecified standards.
Real-time experiences of racism and stress in association with postpartum weight retention: a longitudinal ecological momentary assessment study
Méndez, Dara D. , Tapia, Amanda L. , Sanders, S A, Casas, Andrea , Smalls, Marquita, Davis, Esa M. , Rathbun, Stephen L. , Burke, Lora E. , Omowale, Serwaa S. , Adodoadji, Linda , Gianakas, John , Lai, Y , Feghali, Maisa , Wallace, Meredith L. , Méndez, Dara M , Sanders, Sarah A , Casas, Andrea D , Gary-Webb, Tiffany L , Burke, Lora E , Omowale, Serwaa S , Adodoadji, Linda A , Gianakas, John J , Lai, Y , Feghali, Maisa , Wallace, Meredith L , Smalls, Marquita, Davis, Esa M

Mayo Clinic

American Journal of Epidemiology | November 11, 2024 | Volume: 194 | Issue: 8 | Pages: 2200-2210

10.1093/aje/kwae424 | PMID 39526406 Get It

Abstract Racial inequities in postpartum weight have been documented with limited studies on the influences of racism and other forms of discrimination. In a prospective longitudinal study applying ecological momentary assessment (EMA) and ambulatory assessment of weight, we measured the association between discrimination, stress, and postpartum weight change. The Postpartum Mothers Mobile Study is a cohort of 313 pregnant and birthing individuals who were followed during their second and third trimesters through 1 year postpartum. They were recruited in clinical settings between 2017 and 2020 in a major city center in Pennsylvania. Measures of racism and gender-based discrimination were collected via random EMA surveys throughout pregnancy and postpartum, and weight was collected via Bluetooth-enabled scales at least weekly. Among Black participants, a 10% increase in the number of days a participant experienced racial discrimination in the past month was associated with retaining 0.3 more pounds, a 10% increase in EMA gender discrimination was associated with retaining 0.4 more pounds, and EMA stress reported in the past month was associated with decreased weight retention. Chronic experiences of racial and gender discrimination may contribute to weight retention immediately after pregnancy and beyond.
ReNeu: A Pivotal, Phase IIb Trial of Mirdametinib in Adults and Children With Symptomatic Neurofibromatosis Type 1-Associated Plexiform Neurofibroma
Moertel, Christopher L. , Hirbe, Angela C. , Shuhaiber, Hans, Bielamowicz, Kevin , Sidhu, Alpa , Viskochil, David , Lokku, Armend, Smith, L. Mary, Foreman, Nicholas K. , Hajjar, Fouad, McNall‐Knapp, Rene , Weintraub, Lauren , Antony, Reuben , Franson, Andrea , Schiff, David , Walbert, Tobias , Ambady, Prakash , Bota, Daniela A. , Campen, Cynthia , Kaur, Gurcharanjeet , Maraka, Stefania , Nevel, Kathryn , Aguilar-Bonilla, Ana , Chagnon, Sarah, Dalvi, Nagma , Gupta, Punita , Khatib, Ziad, Metrock, Laura K. , Roberts, Ryan D. , Sadighi, Zsila , Babovic‐Vuksanovic, Dusica , Investigators, for the ReNeu Trial, Raslan, Ahmed M. , Franson, Andrea T., Walter, Andrew , Schiff, David, Hajjar, Fouad M., Slopis, John M. , Klesse, Laura J., Nghiemphu, Leia, Mrugała, Maciej M. , Schmidt, Mary Lou, Foreman, Nick K., Moots, Paul L., Antony, Rueben, Merrell, Ryan , Chagnon, Sarah, Maraka, Stefania, Khatib, Ziad, Foreman, Nicholas K , Franson, Andrea , Meade, Julia , Walbert, Tobias , Klesse, Laura J , Moots, Paul L , Bornhorst, Miriam , Aguilar-Bonilla, Ana , Gupta, Punita , Metrock, Laura K , Nghiemphu, P Leia , Roberts, Ryan D , Babovic-Vuksanovic, Dusica, Gershon, Timothy R , Hirbe, Angela C , Weber, Michael , Klesse, Laura J. , Bornhorst, Miriam , Nghiemphu, Phioanh L. , Robison, Nathan John , Stapleton, Stacie L. , Gershon, Timothy R. , Investigators, for the ReNeu Trial, Franson, Andrea T., Tine, Brian A. Van , Koschmann, Carl , Schiff, David, Hajjar, Fouad M., Capal, Jamie K. , Gill, Jonathan Benjamin , Klesse, Laura J., Kilburn, Lindsay Baker , Foreman, Nick K., Moots, Paul L., Dhamija, Radhika , Antony, Rueben, Chagnon, Sarah, Maraka, Stefania, Khatib, Ziad

Mayo Clinic

Journal of Clinical Oncology | November 8, 2024 | Volume: 43 | Issue: 6 | Pages: 716-729

10.1200/jco.24.01034 | PMID 39514826 Get It

PURPOSE Pharmacologic therapies for neurofibromatosis type 1-associated plexiform neurofibromas (NF1-PNs) are limited; currently, none are US Food and Drug Administration–approved for adults. METHODS ReNeu is an open-label, multicenter, pivotal, phase IIb trial of mirdametinib in 58 adults (≥18 years of age) and 56 children (2 to 17 years of age) with NF1-PN causing significant morbidities. Patients received mirdametinib capsules or tablets for oral suspension (2 mg/m 2 twice daily, maximum 4 mg twice daily), regardless of food intake, in 3 weeks on/1 week off 28-day cycles. The primary end point was confirmed objective response rate (ORR; proportion of patients with a ≥20% reduction of target PN volume from baseline on consecutive scans during the 24-cycle treatment phase) assessed by blinded independent central review (BICR) of volumetric magnetic resonance imaging. RESULTS Twenty-four of 58 adults (41%) and 29 of 56 children (52%) had a BICR-confirmed objective response during the 24-cycle treatment phase; in addition, two adults and one child had confirmed responses during long-term follow-up. Median (range) target PN volumetric best response was –41% (−90 to 13) in adults and –42% (−91 to 48) in children. Both cohorts reported significant and clinically meaningful improvement in patient- or parent proxy-reported outcome measures of worst tumor pain severity, pain interference, and health-related quality of life (HRQOL) that began early and were sustained during treatment. The most commonly reported treatment-related adverse events were dermatitis acneiform, diarrhea, and nausea in adults and dermatitis acneiform, diarrhea, and paronychia in children. CONCLUSION In ReNeu, the largest multicenter NF1-PN trial reported to date, mirdametinib treatment demonstrated significant confirmed ORRs by BICR, deep and durable PN volume reductions, and early, sustained, and clinically meaningful improvement in pain and HRQOL. Mirdametinib was well-tolerated in adults and children.
Intraoperative Acoustic Monitoring Using Threshold and Suprathreshold Pure Tone Audiometry during Cochlear Implantation Under Local Anesthesia: A Simple and Novel Method to Potentially Enhance Hearing Preservation Cochlear Implant Surgery
Khandalavala, Karl R. , Ostlie, Sarah E., Wallerius, Katherine P. , Lohse, Christine M. , Lohmann, Amanda R., Ladsten, Max M., Carlson, Matthew L., Carlson, Matthew L.

Mayo Clinic

Otology & Neurotology | November 8, 2024 | Volume: 46 | Issue: 1 | Pages: 48-53

10.1097/mao.0000000000004369 | PMID 39511748 Get It

Objective To report the feasibility and potential utility of monitoring acoustic hearing on awake patients using intraoperative behavioral responses to threshold and suprathreshold stimuli while undergoing cochlear implantation (CI) under local anesthesia, without any form of sedation. Study Design Retrospective review of the first five cases performed by one surgeon. Setting Tertiary care academic medical center. Patients Adult patients with residual acoustic hearing undergoing CI. Interventions CI under local anesthesia, without any form of sedation. Main Outcome Measures Procedural tolerance, reliability of intraoperative pure tone threshold and suprathreshold audiometry, and correlation of intraoperative findings with early postoperative residual hearing. Results Five ears in four patients underwent CI, including three males and one female, with a median age of 61 years. Intraoperatively, patients reported reliable behavioral responses to pure tone threshold and suprathreshold stimuli and provided real-time feedback on perceived stimulus change to the surgeon just prior to, during, and immediately following electrode insertion. All patients were able to complete the operation under local anesthesia. During electrode insertion, three cases reported no change and two cases reported diminished stimulus perception that reversed with limited electrode pull back near terminal insertion. Immediate postoperative audiograms demonstrated preservation of bone conduction thresholds within 10 dB of their preoperative baseline for all cases, suggesting hearing preservation. Three-month postoperative AzBio in quiet scores were available for two patients, measuring 45% and 94%, respectively. Conclusions This report describes the feasibility of intraoperative behavioral audiometry during CI under local anesthesia, using patient feedback during electrode insertion to optimize hearing preservation surgery. Akin to other surgical subspecialties that use real-time patient feedback where objective intraoperative measures of neurofunction are imperfect, we demonstrate feasibility and potential utility of live acoustic monitoring during CI.
Prospective observational study and mechanistic evidence showing lipolysis of circulating triglycerides worsens hypertriglyceridemic acute pancreatitis
Rajalingamgari, Prasad , Khatua, Biswajit , Summers, Megan J., Elmallahy, Mohamed , Anand, Arti, Pillai, Anoop Narayana, Morsy, Mahmoud , Trivedi, Shubham , McFayden, Bryce , Jahangir, Sarah , Snozek, Christine L.H. , Singh, Vijay , Singh, Vijay P , Summers, Megan E., Kostenko, Sergiy , Chang, Yu‐Hui , Anand, Arti

Mayo Clinic

Journal of Clinical Investigation | November 7, 2024 | Volume: 135 | Issue: 1 | Pages: No page available

10.1172/jci184785 | PMID 39509346 Get It

BACKGROUND While most hypertriglyceridemia is asymptomatic, hypertriglyceridemia-associated acute pancreatitis (HTG-AP) can be more severe than AP of other etiologies. The reasons underlying this are unclear. We thus examined whether lipolytic generation of nonesterified fatty acids (NEFAs) from circulating triglycerides (TGs) could worsen clinical outcomes. METHODS Admission serum TGs, NEFA composition, and concentrations were analyzed prospectively for 269 patients with AP. These parameters, demographics, and clinical outcomes were compared between HTG-AP (TGs >500 mg/dL; American Heart Association [AHA] 2018 guidelines) and AP of other etiologies. Serum NEFAs were correlated with serum TG fatty acids (TGFAs) alone and with the product of TGFA serum lipase (NEFAs – TGFAs × lipase). Studies in mice and rats were conducted to understand the role of HTG lipolysis in organ failure and to interpret the NEFA-TGFA correlations. RESULTS Patients with HTG-AP had higher serum NEFA and TG levels and more severe AP (19% vs. 7%; P < 0.03) than did individuals with AP of other etiologies. Correlations of long-chain unsaturated NEFAs with corresponding TGFAs increased with TG concentrations up to 500 mg/dL and declined thereafter. However, NEFA – TGFA × lipase correlations became stronger with TGs above 500 mg/dL. AP and intravenous lipase infusion in rodents caused lipolysis of circulating TGs to NEFAs. This led to multisystem organ failure, which was prevented by pancreatic TG lipase deletion or lipase inhibition. CONCLUSIONS HTG-AP is made severe by the NEFAs generated from intravascular lipolysis of circulating TGs. Strategies that prevent TG lipolysis may be effective in improving clinical outcomes for patients with HTG-AP. FUNDING National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK, NIH) (RO1DK092460 and R01DK119646); Department of Defense (PR191945 under W81XWH-20-1-0400); National Institute on Alcohol Abuse and Alcoholism (NIAAA), NIH (R01AA031257).
588 EVEREST-1: initial safety data from a seamless phase 1/2 study of A2B530, a logic-gated Tmod CAR T-cell therapy, in patients with solid tumors associated with CEA expression also exhibiting HLA-LOH
Grierson, Patrick , Welling, Theodore H., Lim, Kian-Huat, Morelli, Maria Pia , Patel, Sandip Pravin , Ulrickson, Matthew L. , Kundranda, Madappa N. , Vong, Judy, Mitchell, Jasmine , Langeberg, Wendy J., Bretzlaff, William, Nikiforow, Sarah , Mardiros, Armen, Maloney, David G. , Liechty, Kirstin B., Hecht, J. Randolph , Go, William Y., Molina, Julian R. , Punekar, Salman R. , Hazim, Antonious , Simeone, Diane M. , Kirtane, Kedar , Lim, Kian-Huat , Castria, Tiago Biachi De , Maus, Marcela V , Locke, Frederick L. , Ng, Eric W

Mayo Clinic

Regular and Young Investigator Award Abstracts | November 5, 2024 | Volume: No volume available | Issue: No issue available | Pages: A670-A671

10.1136/jitc-2024-sitc2024.0588 Get It

Imposter Syndrome Across Surgical Subspecialties: Scratching the Surface
Brown, R.F. , Posid, Tasha , Lund, Sarah , L'Hullier, Joseph C, Sheppard, Olabisi Ololade , Zhang, J. , Zoumpou, Theofano , Bialowas, Christie , Hendershot, Kimberly, Cooper, Amanda Beth , Wu, Esther , Zhang, Jeannette, McKinley, Sophia K. , Wieck, Minna M.

Mayo Clinic

No container title available | November 4, 2024 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.21203/rs.3.rs-5257288/v1 Get It

Abstract Purpose Imposter syndrome (IS) is a “behavioral health phenomenon described as self-doubt of intellect, skills, or accomplishments among high-achieving individuals” that has been associated with psychological distress, burnout, anxiety, and depression, and has also been shown to negatively impact career retention and job performance. Previous studies, while rare, have demonstrated remarkably high rates of IS amongst surgical trainees, but include little information on contributing factors. The purpose of this study was to broadly explore IS in surgical trainees across specialties.Methods An anonymous electronic survey aimed at identifying the prevalence, severity, and underlying factors contributing to IS in surgical trainees was developed by members of the ASE Graduate Surgical Education Committee and distributed to list servs of surgical residents across specialties at twelve institutions. Descriptive statistics, univariate analysis, and multivariable analysis were performed to identify differences in and factors contributing to IS.Results A total of 155 survey responses were received. Seventy-one percent of respondents report significant or intense IS, with women demonstrating more severe IS. Residents identified interactions with peers or other residents as triggering more feelings of IS compared to faculty or patients. Prior IS training, feeling a sense of belonging in residency, and lower incidence of microaggressions were associated with less severe IS.Conclusions IS remains prevalent and severe amongst surgical trainees. Although previous work has identified many personal factors that contribute to IS, this study is one of the first of its kind to identify environmental and experiential (context-dependent) factors associated with more severe IS.
Prehabilitative/rehabilitative exercise, nutrition, and psychological support for bladder cancer: A scoping review of randomized clinical trials
Parke, Sara C. , Beck, Kelsey L., Sinha, Debarshi, Ligten, Matthew J. Van, Bain, Paul , Tyson, Mark D. , Abdul‐Muhsin, Haidar , Quillen, Jaxon , Luigi, Arthur Jason De , Branstiter, Nikki L., Briggs, Logan G , Parke, Sara C , Gill, Vikram, Van Ligten, Matthew J, Quillen, Jaxon K, Dodoo, Christopher A, Psutka, Sarah P , Briggs, Logan , Sinha, Debarshi, Gill, Vikram S. , Dodoo, Christopher , Trinh, Quoc‐Dien , Psutka, Sarah P.

Mayo Clinic

Cancer | November 3, 2024 | Volume: 131 | Issue: 1 | Pages: No page available

10.1002/cncr.35608 | PMID 39488730 Get It

Abstract The study of prehabilitation and rehabilitation ([p]rehabilitation) to alleviate the sequelae of bladder cancer and its treatment has generated numerous opportunities to improve the quality of life of bladder cancer survivors. The authors conducted a scoping review of randomized clinical trials (RCTs) to identify knowledge gaps in and research directions for (p)rehabilitative support for those affected by bladder cancer. The authors systematically searched six databases and synthesized key findings from RCTs conducted from January 1, 2004, through March 15, 2022, that enrolled participants with bladder cancer, survivors, or caregivers in outpatient (p)rehabilitative programs (e.g., exercise, nutrition, or psychological support). Outcomes were characterized according to eight prespecified, clinically relevant categories. The search retrieved 10,968 records, 27 of which met the inclusion criteria, and 24 described unique RCTs with 2471 enrolled participants. Of 24 interventions, 17 (71%) yielded statistically significant results for the outcome of interest. Only one RCT included a cost‐effectiveness analysis, and only two characterized the efficacy of interventions for caregivers. Of 11 RCTs involving psychological support, eight yielded statistically significant results, as did nine of 11 RCTs with physical exercise interventions, three of four RCTs with educational interventions, three of four RCTs with nutritional support interventions, one of two RCTs with pharmacologic medications, and zero of one RCT with physical therapy. The most promising interventions for inclusion in multimodal, personalized (p)rehabilitation programs included exercise, stress management training, cognitive training, smoking and alcohol cessation counseling, immunonutrition, stoma education, and penile rehabilitation. Further studies of the cost effectiveness and efficacy for caregivers of such interventions are needed. Plain Language Summary In a scoping review of all randomized clinical trials involving prehabilitative or rehabilitative diet, exercise, and psychological support interventions for patients with bladder cancer, survivors, and their caregivers, 17 of 24 (71%) interventions yielded statistically significant improvements in the outcome of interest. Clinicians should consider implementing such interventions for those affected by bladder cancer.
Clinical spectrum of indolent mycosis fungoides with a gamma‐delta (γδ) phenotype: a single institution review including therapy and outcomes
Ufkes, Nicole , Miles, Rodney R., Cipriano, Sarah D. , Bowling, Morgan , Florell, Scott R. , Gaffney, David K. , Wada, D., Tao, Randa , Halwani, Ahmad , Bowling, M.

Mayo Clinic

JEADV Clinical Practice | October 29, 2024 | Volume: 4 | Issue: 1 | Pages: 203-206

10.1002/jvc2.562 Get It

AbstractBackgroundPrimary cutaneous γδ T‐cell lymphoma (CGD‐CTL) is a rare malignancy that classically exhibits an aggressive clinical phenotype.ObjectivesReview cases of mycosis fungoides with a γδ phenotype that demonstrated an indolent clinical course.MethodsRetrospective review of patients diagnosed with MF with a γδ phenotype and an indolent clinical course between 2018 and 2022 treated at the University of Utah.ResultsFive patients ages 4‐81 years old were identified. All presented with clinically persistent patch or plaque‐stage disease, and histopathology showed primarily epidermotropic infiltrates positive for TCR delta via immunostaining. None of these patients have required aggressive treatment with multiagent chemotherapy.ConclusionsThere exists a subset of indolent CGD‐TCL patients who are clinicopathologically distinct from classic CGD‐CTL and clinically resembling indolent MF. Therefore, we prefer the term “MF with γδ phenotype” for these rare cases.